Citations

Mayo Clinic

Showing 10 of 108551 citations.

Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth
Ramos-González, Martín R. , Tarique, Mohammad , Batra, Lalit , Arguc, Feyza, Garza-Morales, Rodolfo , Shirwan, Haval , Yolcu, Esma S. , Gómez-Gutiérrez, Jorge G. , Garza-Morales, Rodolfo , Arguc, Feyza Nur

Vaccines | March 21, 2024 | Volume: 12 | Issue: 3 | Pages: 340

10.3390/vaccines12030340 | PMID 38543974 Get It

Natural 4-1BBL (CD137L) is a cell membrane-bound protein critical to the expansion, effector function, and survival of CD8+ T cells. We reported the generation of an active soluble oligomeric construct, SA-4-1BBL, with demonstrated immunoprevention and immunotherapeutic efficacy in various mouse tumor models. Herein, we developed an oncolytic adenovirus (OAd) for the delivery and expression of SA-4-1BBL (OAdSA-4-1BBL) into solid tumors for immunotherapy. SA-4-1BBL protein expressed by this construct produced T-cell proliferation in vitro. OAdSA-4-1BBL decreased cell viability in two mouse lung cancer cell lines, TC-1 and CMT64, but not in the non-cancerous lung MM14.Lu cell line. OAdSA-4-1BBL induced programmed cell death types I and II (apoptosis and autophagy, respectively), and autophagy-mediated adenosine triphosphate (ATP) release was also detected. Intratumoral injection of OAdSA-4-1BBL efficiently expressed the SA-4-1BBL protein in the tumors, resulting in significant tumor suppression in a syngeneic subcutaneous TC-1 mouse lung cancer model. Tumor suppression was associated with a higher frequency of dendritic cells and an increased infiltration of cytotoxic CD8+ T and NK cells into the tumors. Our data suggest that OAdSA-4-1BBL may present an efficacious alternative therapeutic strategy against lung cancer as a standalone construct or in combination with other immunotherapeutic modalities, such as immune checkpoint inhibitors.
Hypofractionated Stereotactic Radiosurgery in the Management of Brain Metastases
Lehrer, Eric J. , Breen, William G. , Singh, Raj , Brown, Paul D. , Sheehan, Jason P. , Palmer, Joshua D. , Trifiletti, Daniel M.

Neurosurgery | March 21, 2024 | Volume: 95 | Issue: 2 | Pages: 253-258

10.1227/neu.0000000000002897 | PMID 38511946 Get It

Stereotactic radiosurgery (SRS) is an important weapon in the management of brain metastases. Single-fraction SRS is associated with local control rates ranging from approximately 70% to 100%, which are largely dependent on lesion and postoperative cavity size. The rates of local control and improved neurocognitive outcomes compared with conventional whole-brain radiation therapy have led to increased adoption of SRS in these settings. However, when treating larger targets and/or targets located in eloquent locations, the risk of normal tissue toxicity and adverse radiation effects within healthy brain tissue becomes significantly higher. Thus, hypofractionated SRS has become a widely adopted approach, which allows for the delivery of ablative doses of radiation while also minimizing the risk of toxicity. This approach has been studied in multiple retrospective reports in both the postoperative and intact settings. While there are no reported randomized data to date, there are trials underway evaluating this paradigm. In this article, we review the role of hypofractionated SRS in the management of brain metastases and emerging data that will serve to validate this treatment approach. Pertinent articles and references were obtained from a comprehensive search of PubMed/MEDLINE and clinicaltrials.gov.
Medication regimen complexity among community‐dwelling older adults with incident mild cognitive impairment or dementia
Green, Ariel R. , Jiang, Ruoxiang , Weston, Susan A., Nothelle, Stephanie , Boyd, Cynthia M. , Rocca, Walter A. , Nothelle, Stephanie , Green, Ariel R , Chamberlain, Alanna M. , Sauver, Jennifer L. St.

Journal of the American Geriatrics Society | March 21, 2024 | Volume: 72 | Issue: 7 | Pages: 2241-2244

10.1111/jgs.18877 | PMID 38511683 Get It

Inter‐atrial septal balloon dilation to facilitate intracardiac echocardiography guided left atrial appendage occlusion
Goyal, Sandeep , Bhimani, Ashish A. , Kella, Danesh , Tyagi, Anahita , Polsani, Venkateshwar , Deering, Thomas F. , Goyal, Sandeep K , Kella, Danesh K

Journal of Cardiovascular Electrophysiology | March 21, 2024 | Volume: 35 | Issue: 6 | Pages: 1078-1082

10.1111/jce.16243 | PMID 38509774 Get It

AbstractIntroductionPercutaneous left atrial appendage occlusion (LAAO) is traditionally performed under general anesthesia with trans‐esophageal echocardiography guidance. Intracardiac echo (ICE)‐guided LAAO closure is increasing in clinical use. The ICE catheter is crossed into LA via interatrial septum (IAS) after the septum is dilated with LAAO delivery sheath. This step can be time‐consuming and requires significant ICE catheter manipulation, which increases the risk of cardiac perforation. Pre‐emptive septal balloon dilation can potentially help with ICE advancement in the LA. We sought to evaluate the effect of pre‐dilation of the IAS with an 8 mm balloon on the ease of crossing the ICE catheter, fluoroscopy time for crossing, and overall procedure time.MethodsThe Piedmont LAAO registry was used to identify consecutive patients who underwent LAAO. The initial 25 patients in whom balloon dilation of the IAS was performed served as the experimental cohort, and the 25 consecutive patients before that in whom balloon dilation was not performed served as controls. In the experimental group, after a trans‐septal puncture, the sheath was retracted to the right atrium with a guidewire still in the LA. An 8 × 40 mm Evercoss™ over the wire balloon was inflated across the IAS. The ICE catheter was then crossed into the LA using the fluoroscopic landmark of the guide wire and the ICE imaging. The sheath was then advanced along the ICE catheter via the transseptal puncture (TSP) and the procedure continued. Follow‐up compputed tomography imaging was obtained at 4–8 weeks.ResultsEach group consisted of 25 patients. There were no significant differences in baseline characteristics. All procedures were performed successfully under conscious sedation and ICE guidance. There was a significant reduction in the overall procedure time, fluoroscopy time, and time for transseptal puncture to ICE in LA. There was no difference in the size of the acute residual interatrial shunt, as measured via ICE, or the size and presence of iatrogenic ASD at follow‐up.ConclusionBalloon dilation of TSP is safe and is associated with increased efficiency in ICE‐guided LAAO procedures.
Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
Kamel, Moaz, Scalia, Isabel G. , Badr, Amro , Ali, Nima Baba , Farina, Juan M. , Pereyra, Milagros , Abbas, Mohammed Tiseer , Mahmoud, Ahmed , Scott, Robert L. , Steidley, D. Eric , Rosenthal, Julie , LeMond, Lisa , Hardaway, Brian , Barry, Timothy , Yang, Ming , Jokerst, Clinton, Arsanjani, Reza , Kamel, Moaz A, Badr, Amro T , Baba Ali, Nima, Mahmoud, Ahmed K , Steidley, David E, Rosenthal, Julie L , Lemond, Lisa M , Hardaway, Brian W, Barry, Timothy , Arsanjani, Reza , Farina, Juan M , Pereyra, Milagros , Scalia, Isabel G , Abbas, Mohammed Tiseer , Sell‐Dottin, Kristen , Chao, Chieh‐Ju

Journal of Cardiovascular Development and Disease | March 21, 2024 | Volume: 11 | Issue: 3 | Pages: 95

10.3390/jcdd11030095 | PMID 38535118 Get It

Cardiac allograft vasculopathy (CAV) is a distinct form of coronary artery disease that represents a major cause of death beyond the first year after heart transplantation. The pathophysiology of CAV is still not completely elucidated; it involves progressive circumferential wall thickening of both the epicardial and intramyocardial coronary arteries. Coronary angiography is still considered the gold-standard test for the diagnosis of CAV, and intravascular ultrasound (IVUS) can detect early intimal thickening with improved sensitivity. However, these tests are invasive and are unable to visualize and evaluate coronary microcirculation. Increasing evidence for non-invasive surveillance techniques assessing both epicardial and microvascular components of CAV may help improve early detection. These include computed tomography coronary angiography (CTCA), single-photon emission computed tomography (SPECT), positron emission tomography (PET), and vasodilator stress myocardial contrast echocardiography perfusion imaging. This review summarizes the current state of diagnostic modalities and their utility and prognostic value for CAV and also evaluates emerging tools that may improve the early detection of this complex disease.
The role of glucagon‐like peptide‐1 receptor agonists in metabolic dysfunction‐associated steatohepatitis
Abdelmalek, Manal F. , Abdelmalek, Manal , Harrison, Stephen A. , Sanyal, Arun J.

Diabetes, Obesity and Metabolism | March 21, 2024 | Volume: 26 | Issue: 6 | Pages: 2001-2016

10.1111/dom.15524 | PMID 38511418 Get It

Abstract Despite its considerable and growing burden, there are currently no Food and Drug Administration‐approved treatments for metabolic dysfunction‐associated steatotic liver disease or its progressive form, metabolic dysfunction‐associated steatohepatitis (MASH). Several glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and other agents are in various phases of clinical development for use in MASH; an ideal therapy should reduce liver fat content, improve chronic liver disease, help mitigate metabolic comorbidities and decrease all‐cause mortality. Because of interconnected disease mechanisms, metabolic dysfunction‐associated steatotic liver disease/MASH often coexists with type 2 diabetes (T2D), obesity and cardiovascular disease. Various GLP‐1RAs are Food and Drug Administration‐approved for use in T2D, and two, liraglutide and semaglutide, are approved for overweight and obesity. GLP‐1RAs decrease glucose levels and body weight and improve cardiovascular outcomes in people with T2D who are at high risk of cardiovascular disease. In addition, GLP‐1RAs have been reported to reduce liver fat content and liver enzymes, reduce oxidative stress and improve hepatic de novo lipogenesis and the histopathology of MASH. Weight loss may contribute to these effects; however, the exact mechanisms are unknown. Adverse events that are commonly associated with GLP‐1RAs include vomiting, nausea and diarrhoea. There is a lack of evidence from meta‐analyses regarding the increased risk of acute pancreatitis and various forms of cancer with GLP‐1RAs. Large‐scale, phase 3 trials, which will provide definitive data on GLP‐1RAs and other potential therapies in MASH, are ongoing. Given the spectrum of modalities under investigation, it is hoped that these trials will support the identification of pharmacotherapies that provide clinical benefit for patients with MASH.
The Relationship between Post-Traumatic Stress Disorder Due to Brain Injury and Glutamate Intake: A Systematic Review
Gruenbaum, Benjamin F. , Matalon, Frederic , Shiyntum, Honore N. , Frenkel, Amit , Boyko, Matthew , Matalon, Frederic , Frenkel, Amit , Boyko, Matthew , Gruenbaum, Benjamin Fredrick , Zlotnik, Alexander Anatolievich , Oleshko, Anna

Nutrients | March 21, 2024 | Volume: 16 | Issue: 6 | Pages: 901

10.3390/nu16060901 | PMID 38542812 Get It

There is a growing body of evidence that suggests a connection between traumatic brain injury (TBI) and subsequent post-traumatic stress disorder (PTSD). While the exact mechanism is unknown, we hypothesize that chronic glutamate neurotoxicity may play a role. The consumption of dietary glutamate is a modifiable factor influencing glutamate levels in the blood and, therefore, in the brain. In this systematic review, we explored the relationship between dietary glutamate and the development of post-TBI PTSD. Of the 1748 articles identified, 44 met the inclusion criteria for analysis in this review. We observed that individuals from countries with diets traditionally high in glutamate had greater odds of developing PTSD after TBI (odds ratio = 15.2, 95% confidence interval 11.69 to 19.76, p < 0.01). These findings may support the hypothesis that chronically elevated blood glutamate concentrations caused by high dietary intake invoke neurodegeneration processes that could ultimately result in PTSD. Further studies will clarify whether lowering glutamate via diet would be an effective strategy in preventing or treating post-TBI PTSD.
Postnatal survival of phrenic motor neurons is promoted by BDNF/TrkB.FL signaling
Brandenburg, Joline E. , Fogarty, Matthew J. , Zhan, Wen‐Zhi, Kopper, Leo A., Sieck, Gary C. , Sieck, Gary , Fogarty, Matthew J

Journal of Applied Physiology | March 21, 2024 | Volume: 136 | Issue: 5 | Pages: 1113-1121

10.1152/japplphysiol.00911.2023 | PMID 38511211 Get It

During early postnatal development, BDNF/TrkB signaling promotes PhMN survival. Inhibition of BDNF/TrkB signaling in early postnatal development does not impact PhMN size. Inhibition of BDNF/TrkB signaling in early postnatal development does not impact the number or CSA of DIAm fibers.
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials
Pai, Rish K. , D’Haens, Geert , Kobayashi, Taku , Jairath, Vipul , Park, Bomina , McGinnis, Kim, Redondo, Isabel, Lipitz, Nicole G., Hunter, Theresa , Jairath, Vipul , Jairath, Vipul , Jairath, V , Jairath, V , Jairath, Vipul , Kobayashi, Taku , Sands, Bruce E , Travis, Simon , Hertogh, Gert D. , Redondo, Isabel , Magro, Fernando

Expert Review of Gastroenterology & Hepatology | March 21, 2024 | Volume: 18 | Issue: 1-3 | Pages: 73-87

10.1080/17474124.2024.2326838 | PMID 38509826 Get It

Ruptured Mycotic Thoracic Aortic Aneurysm in the Setting of Streptococcus Bacteremia with Underlying Colonic Malignancy
Chait, Jesse , Mendes, Bernardo C.

AORTA | March 21, 2024 | Volume: 11 | Issue: 06 | Pages: 198-202

10.1055/s-0044-1779250 | PMID 38508579 Get It

AbstractRuptured mycotic thoracic aortic aneurysms (TAAs) pose complex clinical challenges which are often compounded by existing comorbidities of the typical patient. We present the case of an 85-year-old female presenting emergently with a ruptured mycotic TAA with underlying Streptococcus bacteremia who was successfully treated with a thoracic endograft and antibiotics.